快速检索
年期检索
摘要： Objective To determine the price level of drugs in short supply and conduct affordability evaluations, thus putting forward countermeasures and suggestions for the management of prices of these drugs. Methods Taking the national list of drugs in short supply and the national key monitoring list of clinically essential drugs in short supply as the research objects, the bid-winning prices were searched through various bidding websites across the country, and the price levels of the varieties in the list were evaluated through fixed base price index, median price ratio and other indicators. The per capita income evaluation method was used to evaluate the affordability of the drugs on the list. Results and Conclusion Among the 30 varieties with valid international reference prices, 25 are higher than the international reference prices. The prices of 14 kinds of drugs are 1-5 times higher than the international reference prices. The prices of 10 kinds of drugs are 6-35 times higher than the international reference prices. In rural and urban areas, 50% and 73% of the drugs in short supply cost more than two times of the daily income for each course of treatment. The current price levels of selected drugs in short supply are generally high. It is recommended that these drugs should be classified and managed. Besides, the shortage of drugs should be included in the centralized procurement organized by the state to solve the unstable supply in the market.
